A series of α-cyclodextrin-pentacyclic triterpene conjugates were synthesized and evaluated for anti-HCV entry activities.
Compounds 15 and 18 displayed the highest anti-HCV entry activities with an IC50 of 1.18 μM and 0.25 μM, respectively.
Compounds 15 and 18 exert their inhibitory activity at post-binding step and subsequently prevent virus entry.